Omics research in the field of heart failure: A bibliometric analysis from 2008 to 2024

Zhou Lin, Zihan Wang, Jiankang Wang, Hang Shang, Wenxuan Wang, Jianchang Mao, Yongsheng Huang, Yingzi Cui, Jiajuan GuoMedicine 2025 · DOI

TL;DR

This paper provides a comprehensive bibliometric analysis of "omics" research in heart failure (HF) from 2008 to 2024. It reveals a growing research landscape, identifies key global players, and highlights emerging hotspots like biomarker discovery and precision medicine, offering a roadmap for future research directions.

What Problem Does This Paper Address?

Heart failure (HF) is a major global health challenge, affecting millions and leading to significant hospitalizations. While our understanding of HF's complex mechanisms has advanced, particularly with the advent of omics technologies, there's a need for a structured overview of this rapidly evolving research field. This paper addresses the lack of a comprehensive analysis of HF omics research, aiming to map its temporal and spatial distribution, identify key contributors, and pinpoint current research frontiers and advancements.

Methods

The study employed a bibliometric approach using data from the Web of Science Core Collection (WoSCC). Literature published between January 2008 and December 2024, focusing on HF and omics research, was retrieved. Microsoft Excel 2019 was used for calculating publication volume and growth trends, while CiteSpace 6.2.R4 was utilized for generating visual maps and conducting analyses of authors, institutions, countries, journals, references, and keywords. This allowed for a systematic visualization of research landscapes, collaborations, and emerging themes.

Datasets

The study utilized the Web of Science Core Collection (WoSCC) database. A total of 282 articles were included after filtering for relevance, publication type (articles and reviews), and language (English). No new datasets or benchmarks were introduced; the analysis was based on existing published literature.

Key Insights and Ideas

  • Growing Research Momentum: The number of publications on HF omics research has shown a consistent upward trend, with a notable surge between 2020 and 2021, indicating omics technologies are becoming indispensable tools in HF research.
  • Global Collaboration Landscape: While the US, China, Germany, Italy, and the UK are leading countries in HF omics research, the current level of international collaboration among countries and institutions is relatively weak, suggesting a significant opportunity for enhanced academic exchange.
  • Key Research Themes Emerge: The analysis highlights that HF omics research is increasingly focused on identifying biomarkers for diagnosis and prognosis, achieving precision medicine, and elucidating gene expression mechanisms.
  • Interconnectedness of HF and Other Conditions: The research strongly links HF omics to established cardiovascular conditions like coronary heart disease (CHD), acute myocardial infarction (AMI), and atrial fibrillation (AF), underscoring their role as foundational research areas and potential drivers of HF.

Key Results

  • Publication Trends: A total of 282 articles were analyzed, showing a steady increase in publications over 16 years, with a peak in 2024. The growth trend was fitted with an exponential model, indicating sustained interest.
  • Leading Countries: The United States (38.3%) and China (24.1%) are the top contributors in terms of publication volume.
  • Prominent Institutions: The German Centre for Cardiovascular Research and Harvard University led in publications, while Brigham & Women's Hospital showed the highest centrality.
  • Key Researchers: Zannad, Faiez was identified as the most prolific author.
  • Hotspots: Keywords like "HF," "precision medicine," and "gene expression" emerged as central themes. "Coronary heart disease (CHD)," "acute myocardial infarction (AMI)," and "atrial fibrillation (AF)" were identified as significant research backgrounds and current hotspots.
  • Journal Landscape: Frontiers in Cardiovascular Medicine published the most articles, and journals like European Heart Journal and Circulation had high impact factors, indicating a high quality of research output.

Limitations and Future Work

The authors acknowledge several limitations:

  • Database Exclusivity: The study was limited to the Web of Science Core Collection, potentially excluding relevant publications from other databases.
  • Language and Time Constraints: Publication time and language restrictions might have led to incomplete literature coverage and potential biases.
  • Preliminary Exploration: The visual analysis of literature is considered a preliminary exploration, requiring further in-depth research and validation.
  • Limited Volume: The current volume of studies in HF omics research is relatively limited compared to other research fields.

Future work should aim to:

  • Enhance Collaboration: Foster stronger international collaboration among countries, institutions, and researchers.
  • Broaden Scope: Expand research to include HF comorbidities and multi-organ end-stage pathophysiology, moving beyond isolated HF investigations.
  • Address Ethical Considerations: Strictly adhere to ethical guidelines for biomarker detection and data handling, ensuring proper informed consent and patient privacy.
  • Incorporate More Data: Utilize a larger literature base and potentially other databases to further explore emerging trends and research hotspots.

Summary updated

Abstract

Omics Research in the Field of HF has been steadily increasing year by year. In terms of research directions, hotspots often involve studies related to CHD, AMI, AF, and other associated conditions. Regarding research objectives, the primary focuses include identifying biomarkers, achieving precision medicine, and elucidating gene expression mechanisms.
BibTeX
@inproceedings{lin2025omics,
  author = {Zhou Lin and Zihan Wang and Jiankang Wang and Hang Shang and Wenxuan Wang and Jianchang Mao and Yongsheng Huang and Yingzi Cui and Jiajuan Guo},
  title = {{Omics research in the field of heart failure: A bibliometric analysis from 2008 to 2024}},
  booktitle = {Medicine},
  year = {2025},
  doi = {10.1097/md.0000000000045234},
}
Figure